Oxolam (Ciclopirox Olamine)

Oxolam is an antifungal agent that is applied to treat infections of the skin and its appendages.

• Athlete’s foot (tinea tarsalis): reduces fungal growth and relieves itching and scaling.
• Jock itch (tinea cruris): eliminates the causative dermatophytes and improves skin comfort.
• Ringworm (tinea corporea): clears the infection and promotes healing of lesions.
• Seborrheic dermatitis: helps control Malassezia‑related flaking and redness.
• Onychomycosis (nail fungus): supports gradual clearance of fungal elements from the nail plate.

• Ciclopirox olamine exerts its antifungal activity by chelating polyvalent cations such as Fe³⁺ and Al³⁺, which disrupts metal‑dependent enzymatic systems within the fungal cell. This interference impairs cellular respiration, membrane transport and essential biosynthetic pathways, leading to inhibition of fungal growth and eventual cell death.

Adverse reactions to Oxolam are generally mild and limited to the site of application.

Common Side Effects

• Local burning or stinging sensation.
• Mild itching or erythema.
• Dryness or peeling of the treated skin.
• Contact dermatitis in sensitive individuals.

Serious or Rare Side Effects

• Severe allergic reaction (angio‑edema, anaphylaxis).
• Extensive skin blistering or ulceration.
• Persistent worsening of the infection despite therapy.
• Systemic hypersensitivity manifestations such as fever or lymphadenopathy.

When using Oxolam, follow these safety guidelines:

• Application frequency: adhere to the prescribed number of applications per day.
• Treatment duration: complete the full course even if symptoms improve.
• Skin integrity: avoid use on severely damaged or inflamed skin unless directed by a clinician.
• Concomitant topical agents: do not combine with other medicated creams without professional advice.
• Pediatric use: consult a healthcare professional before treating children under the recommended age.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Oxolam has a low potential for systemic drug interactions, but caution is advised in the following situations:

Major Interactions (Avoid)

• Concurrent use with other topical antifungals containing the same active ingredient, which may increase local irritation.

Moderate Interactions (Monitor Closely)

• Application over skin pre‑treated with corticosteroids, which can alter absorption.
• Use together with photosensitizing agents, increasing risk of phototoxic reactions.
• Co‑administration with occlusive dressings that trap moisture and enhance drug penetration.
• Combination with systemic antifungal therapy, requiring monitoring for overlapping toxicity.
• Use on extensive body surface areas, which may raise systemic exposure.